- All sections
- A - Human necessities
- A61B - Diagnosissurgeryidentification
- A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
Patent holdings for IPC class A61B 5/1473
Total number of patents in this class: 1700
10-year publication summary
|
128
|
129
|
200
|
160
|
200
|
156
|
147
|
132
|
139
|
121
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| DexCom, Inc. | 1769 |
248 |
| Abbott Diabetes Care Inc. | 2075 |
201 |
| Medtronic MiniMed, Inc. | 1786 |
145 |
| Roche Diabetes Care, Inc. | 1496 |
49 |
| The Regents of the University of California | 20868 |
41 |
| Medtrum Technologies Inc. | 364 |
34 |
| Senseonics, Incorporated | 322 |
27 |
| F. Hoffmann-La Roche AG | 7796 |
26 |
| Terumo Kabushiki Kaisha | 5865 |
26 |
| Roche Diabetes Care GmbH | 692 |
25 |
| Uxn Co., Ltd. | 38 |
24 |
| California Institute of Technology | 4038 |
23 |
| Cardiac Pacemakers, Inc. | 2804 |
19 |
| Verily Life Sciences LLC | 934 |
18 |
| ARKRAY, Inc. | 857 |
17 |
| Otsuka Pharmaceutical Co., Ltd. | 1508 |
17 |
| PHC Holdings Corporation | 708 |
17 |
| Bionime Corporation | 144 |
15 |
| Ascensia Diabetes Care Holdings AG | 598 |
13 |
| Biolinq, Inc. | 144 |
13 |
| Other owners | 702 |